Breaking: UPC hits NanoString with European sales ban

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Breaking: UPC hits NanoString with European sales ban

Munich.jpg

The decision marks the first time the Unified Patent Court has issued a preliminary injunction after an oral hearing involving both sides in a dispute

The Unified Patent Court granted US biotech company 10x Genomics a preliminary injunction against rival NanoString today, September 19, in a major first for the new court.

Presiding Judge Matthias Zigann, who handed down the order, said the UPC would decide on another PI request on October 10.

It was initially expected that there would be a decision on both applications today.

NanoString can challenge today’s decision at the UPC Court of Appeal in Luxembourg.

The order marks the first time the UPC has issued a PI after hearing oral arguments between both parties in a dispute since the court started hearing cases in June.

The UPC previously issued an ex parte injunction in a dispute between Swiss bike manufacturers myStromer and Revolt Zycling.

Today’s order comes after a hearing at the Munich local division on September 6. Sources who attended that hearing had told Managing IP that an injunction was likely.

One of 10x’s lawyers, Bardehle Pagenberg partner Tilman Müller-Stoy, described the judges as among the best-prepared he had seen in his career after the hearing.

Zigann heard the case alongside three other judges – Tobias Pichlmaier, András Kupecz, and Eric Enderlin.

The PI is the second injunction 10x has obtained from a court in Germany against NanoString so far this year.

The Munich Regional Court issued an anti-anti-suit injunction against NanoString in April, believed to be the first order of its kind in a German life sciences suit.

The order forced NanoString to withdraw an anti-suit injunction it had filed at the US District Court for the District of Delaware.

more from across site and SHARED ros bottom lb

More from across our site

Our latest update also includes the latest case filing statistics, and an update on how a transatlantic merger could be a UPC opportunity for the US half of the partnership
New partners, from biotech company Leyden Labs and Novartis, take the total number of partner hires to 12 since the firm took on external investment in late 2024
Labelled the ‘largest law firm merger in history’, the new outfit could also spell an opportunity for US clients to capitalise on Hogan Lovells' UPC expertise
Andy Lee and Amy Brooks of Brandsmiths explain how the firm secured a win for Peppa Pig over rival children’s character Wolfoo, in a case that centred on copied audio clips
Pedro Moreira outlines proposals by INPI that look set to open a discussion regarding biological materials, extracts, sequences, genetically edited plants, and computer programs
The combined firm, which has a newly appointed IP partner in London, brings together more than 3,500 practitioners across 52 offices, with flagship hubs in Seattle, London, Sydney and New York
A host of SEP-rich law firms, both leading arguments and as intervenors, are set to feature in the UK Supreme Court’s third FRAND episode, though one ground of appeal has been settled
Law firms are investing in generative engine optimisation and boosting their online presence in the hope of gaining a new client base
A decision on a licensing rate payable by Warner Bros and Paramount, and a survey outlining UK businesses’ lack of IP preparation ahead of launching abroad, were among other major talking points
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
Gift this article